Skip to content

Study on the Effect of Durvadi Oil in the Treatment of Eczema (Vicharchika).

A pharmaco-clinical study to evaluate the effectiveness of Durvadi Tail (Cynodon dactylon(l.)pers.) in the management of Vicharchika w.s.r. to Eczematous Dermatoses - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111601
Enrollment
60
Registered
2026-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

State Ayurvedic College and Hospital,Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1- Age group: Between 18 to 70 years. 2- The patients with classical lakshana(s) of Vicharchika irrespective of chronicity will be selected. 3- Both new and chronic cases of Vicharchika w.s.r. to ECZEMATOUS DERMATOSES will be treated, and 4- Patients willing to participate in above mentioned trial.

Exclusion criteria

Exclusion criteria: 1- Age group: Less than 18 years and more than 70 years 2- Any sensitivity reaction to the preparation 3- Skin cancer, psoriasis, etc associated with fungal infection 4- Pregnant and lactating women 5- Diabetics and immune compromised people.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Durvadi Tail in the management of Vicharchika with special reference to Eczematous Dermatoses.Timepoint: Patient enrolled in this group will be evaluated for the outcomes after 2 month of the therapy.

Secondary

MeasureTime frame
To examine the drug of sample DURVA for the pharmacognostical properties & comparing it with the standard sample given in API.Timepoint: Patient enrolled in this group will be evaluated for the outcomes after 2 month of the therapy.

Countries

India

Contacts

Public ContactDr Ramanand

State Ayurvedic College and Hospital,Lucknow

dr.ramanand72@gmail.com9415593858

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026